Moderna, Inc.
MRNA
$27.12
$0.903.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.56% | -90.83% | |||
| Total Other Revenue | 27.27% | -21.43% | |||
| Total Revenue | 31.48% | -88.82% | |||
| Cost of Revenue | -13.42% | -49.17% | |||
| Gross Profit | 19.21% | 6.37% | |||
| SG&A Expenses | 8.49% | -39.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.41% | -47.65% | |||
| Operating Income | 13.62% | 15.73% | |||
| Income Before Tax | 15.15% | 18.58% | |||
| Income Tax Expenses | 0.00% | 110.94% | |||
| Earnings from Continuing Operations | 15.04% | 13.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.04% | 13.30% | |||
| EBIT | 13.62% | 15.73% | |||
| EBITDA | 15.92% | 14.76% | |||
| EPS Basic | 15.47% | 13.53% | |||
| Normalized Basic EPS | 14.96% | 18.77% | |||
| EPS Diluted | 15.47% | 13.82% | |||
| Normalized Diluted EPS | 14.96% | 18.77% | |||
| Average Basic Shares Outstanding | 0.52% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||